Prophylactic Medicaments Containing Insulin Market

Prophylactic medicaments containing insulin market: discover recently published facts and figures featured by an Ai-driven market research tool. Data include market prices, market size, consumption, imports, production, companies, exports, and trade. There is a breakdown by country, including Latin America, the Middle East, the U.S., Africa, the U.K., EU, Russia, and China. Market dynamics and outlook to 2030 are also featured in the reports.


Get FREE access to the latest REPORT on the Prophylactic Medicaments Containing Insulin Market. Make informed decisions with market maps on the DASHBOARD. Download datasets on the TABLE page.

Prophylactic Medicaments Containing Insulin - World's Largest Markets

RatingCountry
1China
2Russia
3Germany
4United States
5Iran

In value terms, China led the market, alone. The second position in the ranking was occupied by Russia. It was followed by Germany.

In China, the prophylactic medicaments containing insulin market expanded at an average annual rate of +8.9% over the period from 2018-2020. The remaining consuming countries recorded the following average annual rates of market growth: Russia (+5.4% per year) and Germany (+1.0% per year).

Prophylactic Medicaments Containing Insulin Prices

Lowest Prices - FOB - Top Exporters

COUNTRY201820192020CAGR,
2018-2020
USD per ton
Brazil401923832526894-18.2%
India29959476345662237.5%
United States9230410019777713-8.2%
France217581201618214802-0.6%
Germany349154293465222242-20.2%
Italy3455143612373712773.7%
China42356745767763088622.0%
Average254228246104199166-11.5%

Prices varied noticeably by the country of origin; the country with the highest price was China ($630,886 per ton), while Brazil ($26,894 per ton) was amongst the lowest.

From 2018 to 2020, the most notable rate of growth in terms of prices was attained by India, while the other global leaders experienced more modest paces of growth.

Highest Prices - CIF - Top Importers

COUNTRY201820192020CAGR,
2018-2020
USD per ton
China30318945107144522621.2%
France29682316804039314315.1%
Japan3088582851333140480.8%
Germany2657212838923125598.5%
United States488944417957256196-27.6%
Canada265088211135215860-9.8%
Hungary251088232844215071-7.4%
United Kingdom274263236158197312-15.2%
Spain1710791883351732220.6%
Greece1499539201277427-28.1%
Turkey743837597269747-3.2%
India21807220251659515-47.8%
Pakistan1267618788536445-46.4%
Average237311219534227018-2.2%

Prices varied noticeably by the country of destination; the country with the highest price was China ($445,226 per ton), while Pakistan ($36,445 per ton) was amongst the lowest.

From 2018 to 2020, the most notable rate of growth in terms of prices was attained by China, while the other global leaders experienced more modest paces of growth.

Prophylactic Medicaments Containing Insulin - Top Importers

COUNTRY201820192020CAGR,
2018-2020
billion USD
France0.812.473.4%
United States1.81.61.3-16.2%
Germany0.70.80.810.9%
China0.20.70.776.8%
Japan0.40.40.4-0.3%

In value terms, France ($2.4B), the United States ($1.3B) and Germany ($805M) appeared to be the countries with the highest levels of imports in 2020, with a combined 44% share of global imports. China, Japan, Canada, the UK, Spain, Hungary, India, Turkey, Greece and Pakistan lagged somewhat behind, together comprising a further 27%.

China (+76.8% per year) recorded the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Prophylactic Medicaments Containing Insulin - Top Exporters

COUNTRY201820192020CAGR,
2018-2020
billion USD
Germany32.72.8-2.7%
France1.52.12.321.4%
Italy0.70.80.83.0%
China0.30.40.414.0%
United States0.20.30.436.3%

In value terms, Germany ($2.8B), France ($2.3B) and Italy ($796M) were the countries with the highest levels of exports in 2020, with a combined 82% share of global exports. China, the United States, India and Brazil lagged somewhat behind, together comprising a further 13%.

The United States saw the highest rates of growth with regard to the value of exports, among the main exporting countries over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Prophylactic Medicaments Containing Insulin - Market Forecast

Driven by increasing demand for prophylactic medicaments containing insulin worldwide, the market is expected to continue an upward consumption trend over the next decade. Market performance is forecast to decelerate, expanding with an anticipated CAGR of for the period from 2020 to 2030, which is projected to bring the market volume to by the end of 2030.

Prophylactic Medicaments Containing Insulin - Product Coverage

  • HS 300431 - Medicaments; containing insulin, for therapeutic or prophylactic uses, packaged for retail sale
Store
Blog
Event
World - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.

Africa - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Africa.

Eastern Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Eastern Asia.

South-Eastern Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in South-Eastern Asia.

Latin America and the Caribbean - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Latin America and the Caribbean.

Northern America - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Northern America.

Middle East - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the Middle East.

Southern Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Southern Asia.

Australia and Oceania - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Australia and Oceania.

Central Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$499

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Central Asia.

Geography